As the cystic fibrosis community celebrates advancements in treatment, concerns about affordability persist. CF United, a grassroots advocacy group, highlights a lesser-known factor driving up healthcare costs: Pharmacy Benefit Managers (PBMs).
Amanda Boone sheds light on how these middlemen affect access to life-changing medications:
Comments